NCT05391373

Brief Summary

Breast cancer is the most common type of cancer seen in women worldwide and ranks first. Chemotherapy is one of the commonly used methods of treatment in breast cancer. Physiological and psychological symptoms that occur due to chemotherapy treatment affect women negatively and reduce their quality of life. For this reason, there is a need for an intervention that could decrease psychological symptoms such as stress and improve quality of life in women with breast cancer. In the literature, it is stated that laughter therapy which is one of the non-pharmacological methods, can be an effective nursing intervention to decrease stress and improve the quality of life in women with breast cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 17, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 25, 2022

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 12, 2022

Completed
Last Updated

June 30, 2022

Status Verified

June 1, 2022

Enrollment Period

3 months

First QC Date

May 21, 2022

Last Update Submit

June 29, 2022

Conditions

Keywords

Perceived stressQuality of lifeLaughter therapyBreast cancer

Outcome Measures

Primary Outcomes (1)

  • Perceived Stress Scale

    The scale consists of 14 items in total and was designed to measure how stressful the changing situations in the individual's life are perceived.The scale is a 5-point Likert-type scale with each item ranging from "never (0)" to "very often (4)". 7 of the scale items with positive expressions are scored in reverse and the total score that can be obtained from the scale ranges from 0 to 56. Eskin et al. performed the validity and reliability study of the Turkish version of Perceived Stress Scale and the internal consistency of the scale was determined to be 0.82.

    The scale was filled in the baseline (before the beginning of the Laughter therapy), 5th and 9th weeks.

Secondary Outcomes (1)

  • Quality of Life Scale (SF-12)

    The scale was filled in the baseline (before the beginning of the Laughter therapy), 5th and 9th weeks.

Study Arms (2)

Laughter Therapy Group

EXPERIMENTAL

The women with breast cancer in the intervention group received two sessions of laughter therapy per week for eight weeks.Each laughter therapy session lasted 40 minutes.

Behavioral: Laughter therapy

Control group

NO INTERVENTION

The control group did not receive any intervention during the study period.

Interventions

Each session started with a 10-minute breathing exercise accompanied by relaxing music, followed by 20-minute laughing exercises. Afterwards, the session was ended with a 10-minute meditation accompanied by relaxing music.

Laughter Therapy Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and older women,
  • Stages II or III breast cancer
  • Receiving Pacitaxel chemotherapy regimen per a week

You may not qualify if:

  • Using any complementary and alternative (CAM) treatment method during practice
  • Having psychological diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Bakircay University Health Sciences Faculty

Izmir, 35560, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Laughter Therapy

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asistant Professor

Study Record Dates

First Submitted

May 21, 2022

First Posted

May 25, 2022

Study Start

February 17, 2022

Primary Completion

May 31, 2022

Study Completion

June 12, 2022

Last Updated

June 30, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations